Q4 2024 Revvity Inc Earnings Call Transcript
Key Points
- Revvity Inc (RVTY) achieved 6% organic growth in the fourth quarter, outperforming expectations.
- The company reported a strong adjusted operating margin of over 30% in the fourth quarter.
- Revvity Inc (RVTY) saw significant growth in its Life Science consumables, indicating a positive trend in pharma biotech customer behavior.
- The company successfully integrated recent acquisitions and capitalized on synergy opportunities, contributing to its growth.
- Revvity Inc (RVTY) expanded its strategic partnerships, including a notable collaboration with Genomics England for a large-scale genetic study.
- Revvity Inc (RVTY) continues to face challenges in its high-ticket life science instrumentation segment, with demand not yet fully normalized.
- The company anticipates a 1.5% foreign exchange headwind to overall revenue for 2025.
- Revvity Inc (RVTY) expects a higher adjusted tax rate of approximately 20% in 2025, up from 18.4% in 2024.
- The company's guidance assumes no significant improvement in end markets due to ongoing political and regulatory uncertainties.
- Revvity Inc (RVTY) plans to increase strategic internal investments in 2025, which may impact operating margin expansion.
Hello, everyone, and welcome to Revvity's fourth-quarter 2024 earnings call. My name is Lydia, and I will be your operator today. (Operator Instructions)
I'll now hand you over to Steve Willoughby, Senior Vice President of Investor Relations to begin. Please go ahead when you're ready.
Thank you, operator. Good morning, everyone, and welcome to Revvity's fourth quarter 2024 earnings conference call. On the call with me today are Prahlad Singh, our President and Chief Executive Officer; and Max Krakowiak, our Senior Vice President and Chief Financial Officer.
I'd like to remind you of the Safe Harbor statements outlined in our press release issued earlier this morning and those in our SEC filings. Statements or comments made on this call may be forward-looking statements, which may include, but may not be limited to, financial projections or other statements of the company's plans, objectives, expectations or intentions.
The company's actual results may differ significantly from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
